Sign In
Buy AMLX
Amylyx Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -35.62. In total, the insiders bought 5.73M and sold 836.33K AMLX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-35.62 |
| ● Buy | 5.73M shares |
| ● Sell | 836.33K shares |
|
51% Buy Activity
Strong Negative Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 31, 2025 Sell |
Cohen Joshua B Co-chief Executive Officer |
21 490 Value: $74.5K |
||
|
Mar 31, 2025 Sell |
Mazzariello Gina Chief Legal Officer |
9 192 Value: $32.0K |
||
|
Mar 31, 2025 Sell |
Bedrosian Camille L Chief Medical Officer |
12 425 Value: $43.1K |
||
|
Mar 31, 2025 Sell |
Frates James M Chief Financial Officer |
10 896 Value: $37.8K |
||
|
Mar 20, 2025 Buy |
Zeiher Bernhardt G Director |
10 000 Value: $37.0K |
||
|
Mar 20, 2025 Buy |
Zeiher Bernhardt G Director |
10 000 Value: $37.0K |
||
|
Mar 06, 2025 Buy |
Mazzariello Gina Chief Legal Officer |
63 851 Value: $230.5K |
||
|
Mar 06, 2025 Buy |
Mazzariello Gina Chief Legal Officer |
95 777 Value: $345.8K |
||
|
Mar 06, 2025 Buy |
Bedrosian Camille L Chief Medical Officer |
68 420 Value: $247.0K |
||
|
Mar 06, 2025 Buy |
Bedrosian Camille L Chief Medical Officer |
102 630 Value: $370.5K |
||
|
Mar 06, 2025 Buy |
Klee Justin B. Co-chief Executive Officer |
180 118 Value: $650.2K |
||
|
Mar 06, 2025 Buy |
Klee Justin B. Co-chief Executive Officer |
270 177 Value: $975.3K |
||
|
Mar 06, 2025 Buy |
Cohen Joshua B Co-chief Executive Officer |
180 118 Value: $650.2K |
||
|
Mar 06, 2025 Buy |
Cohen Joshua B Co-chief Executive Officer |
270 177 Value: $975.3K |
||
|
Mar 06, 2025 Buy |
Frates James M Chief Financial Officer |
68 420 Value: $247.0K |
||
|
Mar 06, 2025 Buy |
Frates James M Chief Financial Officer |
102 630 Value: $370.5K |
||
|
Mar 06, 2025 Buy |
Frates James M Chief Financial Officer |
102 630 Value: $370.5K |
||
|
Mar 06, 2025 Buy |
Frates James M Chief Financial Officer |
68 420 Value: $247.0K |
||
|
Mar 06, 2025 Buy |
Cohen Joshua B Co-chief Executive Officer |
270 177 Value: $975.3K |
||
|
Mar 06, 2025 Buy |
Cohen Joshua B Co-chief Executive Officer |
180 118 Value: $650.2K |
||
|
Mar 06, 2025 Buy |
Klee Justin B. Co-chief Executive Officer |
270 177 Value: $975.3K |
||
|
Mar 06, 2025 Buy |
Klee Justin B. Co-chief Executive Officer |
180 118 Value: $650.2K |
||
|
Mar 06, 2025 Buy |
Bedrosian Camille L Chief Medical Officer |
102 630 Value: $370.5K |
||
|
Mar 06, 2025 Buy |
Bedrosian Camille L Chief Medical Officer |
68 420 Value: $247.0K |
||
|
Mar 06, 2025 Buy |
Mazzariello Gina Chief Legal Officer |
95 777 Value: $345.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
